SERIES: Public Workshops | Number 5 of 7 « Previous | Next »

Jan 18

Past Event

Fourth Annual Sentinel Initiative Public Workshop

Audio

Brookings Multimedia content requires JavaScript. Your browser either doesn't have JavaScript or doesn't have it enabled.

Instructions to enable JavaScript.

Summary

The Engelberg Center for Health Care Reform at Brookings hosted the Fourth Annual Sentinel Initiative Public Workshop on Wednesday, January 18, at the Washington Marriott in Washington, DC. This public workshop brought together the stakeholder community for a productive discussion on a variety of topics in active medical product surveillance, including an update on the U.S. Food and Drug Administration’s (FDA’s) Sentinel Initiative; efforts to support the advancement of safety science; and stakeholder perspectives on the Sentinel Initiative’s progress and future direction.

Dr. Stephen Spielberg, the FDA’s newly appointed Deputy Commissioner for Medical Products and Tobacco, provided the morning keynote address.

Event Agenda

  • Welcome and Overview

  • Keynote Address

    • Stephen Spielberg

      U.S. Food and Drug Administration

  • Overview of the Sentinel Initiative: FDA’s Perspective

    • Rachel Sherman

      U.S. Food and Drug Administration

  • Update on Mini-Sentinel Activities: One Tool to Promote Drug Safety

    • Moderator

      mmclellanimage

      Mark B. McClellan

      Director, Health Care Innovation and Value Initiative

      Senior Fellow, Economic Studies

    • Richard Platt

      Harvard Medical School and Harvard Pilgrim Health Care Institute

    • Robert Temple

      U.S. Food and Drug Administration

  • Stakeholder Panel Discussion: Managing Expectations and Communicating Findings from Sentinel

    • Moderator

      mmclellanimage

      Mark B. McClellan

      Director, Health Care Innovation and Value Initiative

      Senior Fellow, Economic Studies

    • Rhonda Medows

      UnitedHealthcare

    • John Santa

      Consumer Reports Health Ratings Center

    • Myrl Weinberg

      National Health Council

    • Elliott Levy

      Bristol-Myers Squibb

    • Ed Staffa

      U.S. Food and Drug Administration

  • Final Remarks

Details

January 18, 2012

8:30 AM - 12:30 PM EST

Washington Marriott at Metro Center

Grand Ballroom

775 12th St. NW

Map

For More Information

Engelberg Center for Health Care Reform

202.797.6114

SERIES: Public Workshops | Number 5